ArticleBMC neurology2025
Unraveling the link: exploring what risk factor for sleep disorders among paediatric migraine.
Article in BMC neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMigraine is closely related to sleep disorders. Vitamin D is known to regulate sleep, cell proliferation and differentiation. The aim of our study was to measure the predictive value of vitamin D for sleep disorders in paediatric migraine. We hypothesized that vitamin D would be apredictor of sleep disorders in paediatric migraine.
methodsWe conducted an analysis of serum vitamin D levels in 150 paediatric migraine. The Pittsburgh Sleep Quality Index (PSQI) was used as a measure of sleep quality. Based on the PSQI scores, the subjects were divided into normal sleep group and sleep disorder group. Correlation analysis and regression analysis were employed to explore the potential etiology of sleep disturbances in paediatric migraine.
resultsThere was significant difference in the prevalence of sleep disorders between paediatric migraine and the control group (Odds ratio [OR] = 4.91,95% confidence interval [CI] = 3.25-7.40, P = 0.001). Additionally, the regression analysis demonstrated that vitamin D could serve as a predictive factor for sleep disorders in paediatric migraine (OR = 0.008, 95%CI: 0.023-0.225, P = 0.004). The receiver operating characteristic (ROC) analysis revealed an area under the curve (AUC) of 0.957 (95% CI 0.925-0.988), with a cutoff value of 15.84 ng/ml, a sensitivity of 87.5%, and a specificity of 93.7% for serum vitamin D.
conclusionOur study confirms the association between sleep disorder and vitamin D levels in paediatric migraine. The use of vitamin D supplementation as a treatment strategy for sleep disturbances in paediatric migraine needs further investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.